Mar 18, 2019 - Novo Nordisk (NVO +0.7%) has settled its Victoza (liraglutide) patent infringement litigation with Teva Pharmaceutical Industries (TEVA -0.1%), allowing the latter launch a generic version the type 2
Mar 11, 2019 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $15.78, marking a +0.19% move from the previous day.
Mar 07, 2019 - Bausch Health's shareholder dilution overhang is noted.Why understanding Bausch Health made me comfortable with Teva.Why I think that Teva is a better investment and more undervalued than Bausch Healt
Mar 07, 2019 - Chiasma (NASDAQ:CHMA) initiated with Overweight rating and $18 (208% upside) price target. Shares up 3% premarket.Mylan N.V. (NASDAQ:MYL) reiterated with Neutral rating and $31 (15% upside) price targ
Mar 06, 2019 - Eli Lilly's (LLY) supplemental biologics license application for its migraine drug, Emgality, wins a priority review from the FDA for treating episodic cluster headache in adults.
Mar 06, 2019 - Teva's 2019 outlook sent investors packing last month.
Mar 06, 2019 - Voyager Therapeutics (NASDAQ:VYGR) initiated with Overweight rating and $27 (52% upside) price target at Cantor Fitzgerald.Mylan N.V. (NASDAQ:MYL) upgraded to Overweight with a $35 (28% upside) price
Feb 26, 2019 - The FDA accepts Alkermes (ALKS) and partner Biogen's NDA for diroximel fumarate and sets an action date in the fourth quarter of 2019.
Feb 25, 2019 - Momenta (MNTA) reported a narrower loss in Q4, while sales came ahead of expectations.
Feb 22, 2019 - Goldentree Asset Management Lp Buys Caesars Entertainment Corp, Teva Pharmaceutical Industries, International Game Technology PLC, Sells Constellium NV, Encana Corp, PG&E Corp, Stocks: BHC,HUN,LILAK,MIK,MTG,NRP,CZR,TEVA,IGT,QRTEA,FBC,G, release date:Feb 22, 2019